New developments such as microdosing and advanced formulations expand your options for a comfortable journey
It makes a lot of sense due to the difference in response and tolerance rates among people who are taking GLP-1 medications
Impaired leptin receptor signaling is a primary mechanism driving weight gain (24, 26), and the role of CCK-A receptor signaling in satiety is well established (31)
Even in diabetic animal models, RYGB and/or VSG reduced -cell dedifferentiation (RYGB, diabetic GotoKakizaki rats) 59 , improved -cell identity markers (VSG, young db/db mice 60,61 ) and increased islet insulin content (RYGB, Zucker diabetic fatty rats 62 )
This is speculative but biologically plausible
Molecular Endocrinology, 27 , 12341244